HELXvsARKGETF Comparison
VS
Franklin Genomic Advancements ETF (HELX) and ARK Genomic Revolution ETF (ARKG) belong to the same industry segment: BioTech & Genomics. HELX's top 3 sector exposures are Healthcare, Non-Energy Materials and Technology. In contrast, ARKG's top sector exposures are Healthcare. HELX is less expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.75% for ARKG. HELX is up 22.14% year-to-date (YTD) with +$8M in YTD flows. ARKG performs better with 76.72% YTD performance, and +$90M in YTD flows. Run a side-by-side ETF comparison of HELX and ARKG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
HELX vs ARKG performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/27/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | HELX ARKG | -0.14%-3.25% | +14.08%+36.71% | +22.14%+76.72% | +28.70%+65.56% | +73.74%+132.21% | -14.82%-29.90% |
| Flows | HELX ARKG | +$2M+$37M | +$2M+$51M | +$8M+$90M | +$8M+$63M | +$17M-$431M | +$8M-$2.01B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | HELX ARKG | +27.09%+49.99% | +23.97%+44.59% | +21.89%+44.73% | +23.66%+46.89% |
| Max drawdown | HELX ARKG | -8.93%-17.81% | -17.89%-27.52% | -29.16%-46.41% | -55.27%-76.56% |
| Max drawdown duration | HELX ARKG | 22d22d | 206d126d | 458d882d | 1820d1818d |
Trading data
HELX | ARKG | |
Last sale 10/28/2026 at 1:30 PM | $45.47 | $54.82 |
| Previous close 10/27/2026 | $44.31 | $51.65 |
| Consolidated volume 10/27/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 10/28/2026 at 1:30 PM
Live
Closed
HELX | ARKG | |
|---|---|---|
| Last price | $45.47 | $54.82 |
| 1D performance | +2.63% | +6.14% |
| AuM | $35.46 M | $2.18 B |
| E/R | 0.5% | 0.75% |
Characteristics
HELX | ARKG | |
|---|---|---|
| Management strategy | Active | Active |
| Provider | Franklin Templeton | Ark Investment |
| Benchmark | - | - |
| N° of holdings | 66 | 31 |
| Asset class | - | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | February 25, 2020 | April 2, 2019 |
| ESG | No | No |
Advertisement
Exposure
Countries
HELX
USA
89.58%
Other
10.42%
ARKG
USA
88.62%
Other
11.38%
Sectors
HELX
Healthcare
96.71%
Other
3.29%
ARKG
Healthcare
97.89%
Other
2.11%
Advertisement
Diversification
HELX
Total weight of top 15 holdings out of 15
60.55%
ARKG
Total weight of top 15 holdings out of 15
74.64%
Top 15 holdings
Data as of August 31, 2026
HELX
Guardant Health, Inc.
9.55%
Natera, Inc.
8.57%
Krystal Biotech, Inc.
5.64%
Adaptive Biotechnologies Corp.
4.49%
Ligand Pharmaceuticals, Inc.
4.22%
Twist Bioscience Corp.
4.19%
BridgeBio Pharma, Inc.
3.44%
United Therapeutics Corp.
3.08%
Travere Therapeutics, Inc.
2.99%
Vertex Pharmaceuticals, Inc.
2.78%
Medpace Holdings, Inc.
2.69%
Corteva, Inc.
2.50%
Eli Lilly & Co.
2.31%
Regeneron Pharmaceuticals, Inc.
2.15%
Repligen Corp.
1.97%
ARKG
10X Genomics, Inc.
9.58%
Twist Bioscience Corp.
9.13%
Tempus AI, Inc.
7.91%
CRISPR Therapeutics AG
6.10%
Personalis, Inc.
5.93%
Absci Corp.
4.88%
Natera, Inc.
4.06%
Illumina, Inc.
4.04%
Eli Lilly & Co.
3.86%
CareDx, Inc.
3.85%
Guardant Health, Inc.
3.81%
Beam Therapeutics, Inc.
3.56%
Compass Pathways Plc
3.17%
Recursion Pharmaceuticals, Inc.
2.44%
Adaptive Biotechnologies Corp.
2.32%
Frequently asked questions about HELX and ARKG
How have the HELX and ARKG ETFs performed in 2026?
As of October 27, 2026, HELX is up 22.14% year-to-date (YTD), while ARKG has returned 76.72%. That puts ARKG better performer ahead so far this year.
Which ETF is attracting more investor money: HELX or ARKG?
Year-to-date, the HELX ETF saw +$8M in flows, compared to +$90M for ARKG.
Which ETF is more volatile: HELX or ARKG?
Over the past year, HELX had a volatility of 23.97%, while ARKG experienced 44.59%.
Which ETF is bigger: HELX or ARKG?
As of October 27, 2026, HELX holds $35.46 M in assets under management (AUM), while ARKG manages $2.18 B.
What sectors do the HELX and ARKG ETFs invest in?
HELX leans toward sectors like Healthcare. Meanwhile, ARKG focuses on Healthcare.
What are the top holdings of the HELX ETF and ARKG ETF?
HELX top holdings include Guardant Health, Inc., Natera, Inc. and Krystal Biotech, Inc.. ARKG holds in its top three: 10X Genomics, Inc., Twist Bioscience Corp. and Tempus AI, Inc..
Which ETF is more diversified: HELX or ARKG?
HELX holds 66 securities with 60.55% of its assets in the top 15. ARKG has 31 securities and a top 15 weight of 74.64%.
Advertisement
Latest news about HELX & ARKG
The Weekly ETF Market Monitor (October 19-23, 2026)
October 26, 2026
ARKG
Biotech ETFs – Investing in Health Innovation
July 21, 2022
ARKG
Advertisement
Advertisement
